Skip to main content
OpenTrials

Clinical trial condition

Thyroid Carcinoma, Anaplastic

Explore clinical trials studying Thyroid Carcinoma, Anaplastic. Study availability and eligibility vary by location and protocol.

55 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Carcinoma, Anaplastic trial results

Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details
Recruiting

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

NCT06902376

Conditions
Anaplastic Thyroid Cancer, BRAF Mutation-Related Tumors, Carcinoma, +11 more
Locations
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Sacituzumab govitEcan in THYroid Cancers

NCT06235216

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Differentiated Thyroid Cancer, +4 more
Locations
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
  • Complexo Hospitalario Universitario de Ferrol Ferrol, Spain
  • Institut Catala d´Oncologia (ICO) -Hospitalet Hospitalet de Llobregat (Barcelona), Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details

Related conditions